Arich Enterprise Co Ltd

Arich Enterprise maintains a liquidity profile that is currently medium, with a negative net cash position after subtracting total debt. The company's liquidity_fpt indicates a cash flow challenge, as operating cash flow is negative at -1903634000.0 TWD, while free cash flow is a modest 58247000.0 TWD. The current ratio of 1.44 suggests the company can cover its short-term liabilities, but the negative operating cash flow raises concerns about its ability to sustain operations without external financing. Profitability metrics show a mixed picture. The company's return on equity (ROE) is 4.32%, which is below the typical benchmark for pharmaceutical firms, and its return on assets (ROA) is 1.65%, indicating underutilization of assets. The gross profit margin is 19.99%, and the operating margin is 6.56%, both of which are in line with industry norms but not exceptional. The price-to-book (P/B) ratio of 0.69 suggests the company is trading at a discount to its book value, which may reflect market skepticism about its asset quality or future earnings potential. The company's revenue is concentrated in Taiwan, as disclosed in its business description, with no material international operations. This geographic concentration exposes the company to local regulatory, economic, and healthcare policy risks. The company's business is entirely within the pharmaceutical distribution and logistics segment, with no diversification into other healthcare services or product lines. Growth trajectory appears modest. The company's revenue in the latest period was 1546999000.0 TWD, and while no specific growth rate is provided, the operating cash flow and free cash flow figures suggest limited reinvestment capacity. The capital expenditure of -7358000.0 TWD indicates minimal investment in new infrastructure or technology, which may constrain long-term growth. The outlook for the current and next fiscal years is not explicitly provided, but the company's financials suggest a conservative approach to expansion. Risk factors include liquidity constraints and the potential for dilution, though the latter is currently assessed as low. The company's debt-to-equity ratio of 0.31 is relatively low, but the negative operating cash flow and reliance on free cash flow for operations could increase financial risk in the event of a downturn. The risk assessment flags a negative net cash position after subtracting total debt, which could necessitate additional financing or asset sales. Recent events include the latest financial filing, which provides a snapshot of the company's financial position as of the most recent period. No recent earnings call transcripts or material regulatory filings are disclosed in the input data. The company's business model and operations remain stable, with no significant changes in its core distribution and logistics services.